Knowledge Tree
Relations (1)
related 5.00 — strongly supporting 5 facts
The Montreal model and psilocybin are related through their shared context in psychedelic-assisted psychotherapy, where the Montreal model's ketamine protocol is compared to psilocybin in terms of duration of altered states of consciousness [1], [2], [3], [4]. Furthermore, the clinical implementation strategies developed for the Montreal model are considered relevant for the future transition of psilocybin into standard clinical care [5].
Facts (5)
Sources
The Montreal model: an integrative biomedical-psychedelic ... frontiersin.org 5 facts
measurementThe Montreal model's six intravenous ketamine treatments provide patients with a similar amount of time in an altered state of consciousness as two doses of psilocybin.
procedureThe Montreal model protocol for ketamine treatment involves six relatively brief ketamine infusions over a period of 4 weeks, which differs from the one or two longer psilocybin sessions typically employed in other psychedelic-assisted psychotherapy (PAP) studies.
claimThe Montreal model of ketamine treatment spreads the total duration of altered states of consciousness over 4 weeks, whereas psilocybin treatment typically occurs over one or two sessions.
measurementThe Montreal model's six ketamine treatments yield approximately the same amount of time in an altered state of consciousness as 12 psilocybin treatments, but spread out over multiple sessions.
claimThe challenges and potential solutions described in the Montreal model for ketamine therapy may hold relevance for the upcoming transition of drugs like psilocybin from clinical trials to clinical care.